INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,367 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Option exercise
M—
6,250 sh
Dec 16, 2025Dec 18, 2025
Page 1614 of 1835
← PrevNext →
traded Dec 16, 2025
+2d
SEC Form 4

Evidence

5
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Derivative conversion
C—
6,250 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Option exercise
M—
20.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
69 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Derivative conversion
C—
6,250 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
GS
Ganesan SatishSee Remarks
SYNASYNAPTICS Inc
Tax withholding
F$11K
146 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

5
TA
Thornock Tai A.Chief Accounting Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$25K
1,100 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$3,948
69 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
285 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Option exercise
M—
6,250 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$18K
285 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
1,194 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Grant or award
A—
14.3K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
181 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$19K
181 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$730K
45.0K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

4
SK
Sadowsky KennethDirector
COCOVita Coco Company, Inc.
Open-market sale · 10b5-1 plan
SELL$201K
3,900 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

3
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$149K
18.8K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

3
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
3,760 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion
C—
7,187 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion
C—
7,187 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise
M—
7,187 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

1
HK
Hohenstein KenChief Revenue Officer
OSOneStream, Inc.
Option exercise · 10b5-1 plan
M$426K
40.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

1
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,711
200 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$13K
4,913 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
37.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
HK
Hohenstein KenChief Revenue Officer
OSOneStream, Inc.
Option exercise · 10b5-1 plan
M—
10.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
SS
Sharan SharatDirector, President and Chief Executive, 10% Owner
ONTFON24 INC.
Option exercise · 10b5-1 plan
M$49K
28.9K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
18.8K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$6,994
3,760 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

47
PL
Phanstiel S. LouiseDirector
BFLYButterfly Network, Inc.
Open-market purchase
BUY$571K
185.3K sh
Dec 15, 2025Dec 17, 2025
traded Dec 15, 2025
+2dSEC Form 4

Evidence